|
WO2018229733A1
|
|
Immuno-biomarkers distinguish responsiveness versus non-responsiveness during immunotherapeutic treatments
|
|
CN105983095A
|
|
Respiratory syncytial virus vaccine, and preparation method and application thereof
|
|
CN106535922A
|
|
Immunotherapeutic composition, therapeutic method and diagnostic method
|
|
CN106456745A
|
|
Vaccines with interleukin-17 as an adjuvant
|
|
CN106668852A
|
|
Vaccine for treating and/or preventing type I diabetes and application thereof
|
|
CN104168912A
|
|
Facilitator-DNA combination vaccine
|
|
CN103998055A
|
|
Combined facilitator, antigen and DNA vaccine for preventing and treating autoimmune diseases
|
